Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 10 | 2022 | 1177 | 1.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 363 | 0.300 |
Why?
|
| Transplant Recipients | 2 | 2021 | 137 | 0.260 |
Why?
|
| Heart Transplantation | 1 | 2021 | 717 | 0.250 |
Why?
|
| Organ Preservation Solutions | 1 | 2022 | 28 | 0.210 |
Why?
|
| Brain Death | 1 | 2022 | 82 | 0.190 |
Why?
|
| Hepatitis, Alcoholic | 1 | 2020 | 16 | 0.180 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2020 | 19 | 0.180 |
Why?
|
| Symptom Assessment | 1 | 2020 | 66 | 0.180 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.180 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 173 | 0.170 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 309 | 0.160 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 65 | 0.160 |
Why?
|
| Lung Transplantation | 1 | 2022 | 290 | 0.150 |
Why?
|
| Hernia, Umbilical | 1 | 2017 | 17 | 0.150 |
Why?
|
| Ascites | 1 | 2017 | 56 | 0.140 |
Why?
|
| United States | 6 | 2022 | 6957 | 0.140 |
Why?
|
| Herniorrhaphy | 1 | 2017 | 90 | 0.130 |
Why?
|
| Organ Transplantation | 1 | 2019 | 275 | 0.130 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 254 | 0.130 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 738 | 0.130 |
Why?
|
| Surgeons | 1 | 2019 | 247 | 0.130 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 599 | 0.120 |
Why?
|
| Tissue Donors | 2 | 2022 | 490 | 0.110 |
Why?
|
| Graft Survival | 3 | 2022 | 898 | 0.110 |
Why?
|
| Adult | 8 | 2022 | 26508 | 0.110 |
Why?
|
| Patient Readmission | 1 | 2017 | 351 | 0.110 |
Why?
|
| Organ Preservation | 2 | 2022 | 105 | 0.100 |
Why?
|
| Perfusion | 2 | 2022 | 235 | 0.090 |
Why?
|
| Bilirubin | 1 | 2021 | 129 | 0.090 |
Why?
|
| Diabetes Complications | 1 | 2021 | 170 | 0.090 |
Why?
|
| Humans | 13 | 2022 | 89073 | 0.090 |
Why?
|
| Risk Factors | 4 | 2022 | 5466 | 0.080 |
Why?
|
| Living Donors | 2 | 2022 | 339 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 996 | 0.080 |
Why?
|
| Middle Aged | 6 | 2021 | 25865 | 0.080 |
Why?
|
| Cytokines | 2 | 2022 | 802 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2022 | 8203 | 0.070 |
Why?
|
| Survival Rate | 1 | 2021 | 1889 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2017 | 2275 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 3035 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2022 | 9003 | 0.060 |
Why?
|
| Male | 6 | 2021 | 42254 | 0.060 |
Why?
|
| Female | 6 | 2021 | 46014 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 3657 | 0.060 |
Why?
|
| Prognosis | 1 | 2021 | 3773 | 0.050 |
Why?
|
| Raffinose | 1 | 2022 | 23 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2021 | 4273 | 0.050 |
Why?
|
| Potassium Chloride | 1 | 2022 | 86 | 0.050 |
Why?
|
| Aged | 4 | 2021 | 19078 | 0.050 |
Why?
|
| Allopurinol | 1 | 2022 | 77 | 0.050 |
Why?
|
| Glutathione | 1 | 2022 | 108 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 2291 | 0.050 |
Why?
|
| Leukocytes | 1 | 2022 | 204 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 71 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 120 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 356 | 0.040 |
Why?
|
| Adenosine | 1 | 2022 | 237 | 0.040 |
Why?
|
| Glucose | 1 | 2022 | 630 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 848 | 0.040 |
Why?
|
| Young Adult | 1 | 2021 | 6289 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 464 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6777 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 5320 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2017 | 43 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1592 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 1205 | 0.040 |
Why?
|
| Florida | 1 | 2017 | 57 | 0.040 |
Why?
|
| California | 1 | 2017 | 144 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 1146 | 0.040 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 390 | 0.030 |
Why?
|
| Emergencies | 1 | 2017 | 121 | 0.030 |
Why?
|
| Patient Selection | 1 | 2020 | 682 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1258 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 876 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2017 | 386 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 754 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2017 | 320 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1706 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2612 | 0.020 |
Why?
|
| Child | 1 | 2022 | 7149 | 0.020 |
Why?
|